Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | HDAC6 | Q9UBN7 | 6/20 | 0.42 |
| ▸ | HDAC1 | Q13547 | 4/20 | 0.42 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.41 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.41 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.41 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.41 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.41 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.41 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.41 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.41 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.41 |
| ▸ | HPGDS | O60760 | 1/20 | 0.39 |
| ▸ | OPRM1 | P35372 | 4/20 | 0.39 |
| ▸ | OPRD1 | P41143 | 4/20 | 0.39 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.38 |
| ▸ | HRH3 | Q9Y5N1 | 4/20 | 0.38 |
| ▸ | GRN | P28799 | 1/20 | 0.38 |
| ▸ | SORT1 | Q99523 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21628892 | 1.00 | POLB (0.43) | POLBSMN1; SMN2HDAC6HDAC1HDAC3 | |
| SCHEMBL21628510 | 0.90 | OPRM1 (0.49) | POLBSMN1; SMN2HPGDSOPRM1OPRD1 | |
| SCHEMBL21628508 | 0.90 | OPRM1 (0.49) | POLBSMN1; SMN2HPGDSOPRM1OPRD1 | |
| SCHEMBL23210687 | 0.87 | MAPT (0.43) | POLBSMN1; SMN2OPRM1OPRD1OPRK1 | |
| SCHEMBL23210684 | 0.87 | MAPT (0.43) | POLBSMN1; SMN2OPRM1OPRD1OPRK1 | |
| SCHEMBL23210665 | 0.86 | LMNA (0.51) | POLBSMN1; SMN2OPRM1OPRD1OPRK1 | |
| SCHEMBL23210666 | 0.86 | LMNA (0.51) | POLBSMN1; SMN2OPRM1OPRD1OPRK1 | |
| SCHEMBL21628647 | 0.86 | OPRM1 (0.50) | OPRM1OPRD1OPRK1HRH3 | |
| SCHEMBL21628648 | 0.86 | OPRM1 (0.50) | OPRM1OPRD1OPRK1HRH3 | |
| SCHEMBL21628671 | 0.85 | HDAC6 (0.45) | SMN1; SMN2HDAC6HDAC1HDAC3HDAC11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12600696-B2 | Aromatic compounds | Xeniopro GmbH (DE) | 2026-04-14 | — | — | US | disclosed |
| US-20230406814-A2 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2023-12-21 | — | — | US | disclosed |
| US-20230150923-A1 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2023-05-18 | — | — | US | disclosed |
| US-11591289-B2 | Aromatic compounds | Xeniopro GmbH (DE) | 2023-02-28 | — | — | US | disclosed |
| US-20200031763-A1 | NOVEL AROMATIC COMPOUNDS | Xeniopro GmbH (DE) | 2020-01-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230150923-A1 | NOVEL AROMATIC COMPOUNDS | AHR, TYR, MUSK | POLB 3699/4885SMN1; SMN2 796/4885HDAC6 2604/4885 |
| US-11591289-B2 | Aromatic compounds | AHR, TYR, MUSK | POLB 2979/4885SMN1; SMN2 1107/4885HDAC6 2978/4885 |
| US-12600696-B2 | Aromatic compounds | CCR1, CCRL2, AHR | POLB 814/4885SMN1; SMN2 919/4885HDAC6 1293/4885 |
| US-20230406814-A2 | NOVEL AROMATIC COMPOUNDS | AHR, TYR, MUSK | POLB 3699/4885SMN1; SMN2 796/4885HDAC6 2604/4885 |
| US-20200031763-A1 | NOVEL AROMATIC COMPOUNDS | AHR, TYR, MUSK | POLB 3699/4885SMN1; SMN2 796/4885HDAC6 2604/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.